#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vulval cancer recurrent Gastrointestinal stromal tumour Liposarcoma Li-Fraumeni syndrome Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Plasma cell myeloma Synovial sarcoma Angelman's syndrome Neurodermatitis Congenital megacolon Glomerulonephritis membranoproliferative High-grade B-cell lymphoma Idiopathic pulmonary fibrosis Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Canavan disease More trials…

    Learn about Rare Diseases

    Antithrombin III deficiency – Trials in Disease Sarcoidosis – Life with Disease Haemolytic uraemic syndrome Nephrotic syndrome – Basic Information Glycogen storage disease type I – Diagnostics Mantle cell lymphoma – Treatment Hereditary hypophosphataemic rickets – Basic Information Brain stem glioma – Trials in Disease VEXAS syndrome Fabry’s disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Buloxibutid AGALSIDASE BETA Ripasudil Acenocoumarol RNMB3 Tasquinimod BENZYLPENICILLIN PROCAINE Clindamycin Phosphate Propranolol Hydrochloride Tilmanocept Elivaldogene Autotemcel Valine Glimepiride Florbetaben (18F) Etrumadenant Levofloxacin Orlistat Insulin Human (Rdna) Fosaprepitant Doravirine More therapies…

    Learn about Your Condition

    Thalassaemia alpha Oxygen saturation Juvenile absence epilepsy Haemodynamic instability Thymic carcinoma Sarcoidosis Peritoneal abscess Cardiac failure chronic Short-bowel syndrome Eosinophilic oesophagitis Laparoscopic surgery Myeloid leukaemia Pain in extremity Metachromatic leukodystrophy Bone metabolism disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on the Safety and Effectiveness of Emtricitabine and Tenofovir Alafenamide for HIV-1 Prevention in Men and Transgender Women at Risk

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Emtricitabine
    • Tenofovir Alafenamide
    Austria Denmark France Germany Ireland Italy +1

  • Study on the Safety of BIMERVAX and Fluad Tetra for COVID-19 and Influenza in Adults Over 65 Who Are Fully Vaccinated Against COVID-19

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Influenza
    • COVID-19
    Investigated Drugs:
    • A/DARWIN/9/2021 (H3N2) – LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
    • SARS-COV-2 VIRUS, VARIANTS B.1.351-B.1.1.7, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN FUSION HETERODIMER
    • A/Victoria/2570/2019 (H1N1)Pdm09-Like Strain (A/Victoria/2570/2019, Ivr-215)
    Spain

  • Study Comparing Intradermal and Intramuscular Rabies Vaccination with Inactivated Rabies Virus for Patients Needing a Booster Dose

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rabies
    Belgium

  • Study on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • A/DARWIN/9/2021 (H3N2) – LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
    • Influenza Virus A/Thailand/8/2022 (H3N2) Ivr-237-Like Strain (A/Thailand/8/2022)
    • A/Victoria/4897/2022 (H1N1)Pdm09-Like Strain (A/Victoria/4897/2022, Ivr-238)
    Belgium Bulgaria Czechia Finland Italy Lithuania +4

  • Study on Sofosbuvir for Preventing Yellow Fever in Healthy Volunteers

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • SOFOSBUVIR
    The Netherlands

  • Study on the Immune Response and Safety of RSVPreF3 Vaccine in Adults 18+ with Lung or Kidney Transplants at Risk of RSV Infections, Compared to Healthy Adults 50+

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
    Germany Italy Spain
Previous Page
1 … 31 32 33 34 35 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!